Plasma Levels of Transforming Growth Factor-β1 Reflect Left Ventricular Remodeling in Aortic Stenosis

Abstract

BackgroundTGF-β1 is involved in cardiac remodeling through an auto/paracrine mechanism. The contribution of TGF-β1 from plasmatic source to pressure overload myocardial remodeling has not been analyzed. We investigated, in patients with valvular aortic stenosis (AS), and in mice subjected to transverse aortic arch constriction (TAC), whether plasma TGF-β1 relates with myocardial remodeling, reflected by LV transcriptional adaptations of genes linked to myocardial hypertrophy and fibrosis, and by heart morphology and function.Methodology/Principal FindingsThe subjects of the study were: 39 patients operated of AS; 27 healthy volunteers; 12 mice subjected to TAC; and 6 mice sham-operated. Myocardial samples were subjected to quantitative PCR. Plasma TGF-β1 was determined by ELISA. Under pressure overload, TGF-β1 plasma levels were significantly increased both in AS patients and TAC mice. In AS patients, plasma TGF-β1 correlated directly with aortic transvalvular gradients and LV mass surrogate variables, both preoperatively and 1 year after surgery. Plasma TGF-β1 correlated positively with the myocardial expression of genes encoding extracellular matrix (collagens I and III, fibronectin) and sarcomeric (myosin light chain-2, β-myosin heavy chain) remodelling targets of TGF-β1, in TAC mice and in AS patients.Conclusions/SignificanceA circulating TGF-β1-mediated mechanism is involved, in both mice and humans, in the excessive deposition of ECM elements and hypertrophic growth of cardiomyocytes under pressure overload. The possible value of plasma TGF-β1 as a marker reflecting preoperative myocardial remodeling status in AS patients deserves further analysis in larger patient cohorts.

Changes and Prognostic Impact of Apoptotic and Inflammatory Cytokines in Patients Treated with Cardiac Resynchronization Therapy

“…The plasma concentration of TGF-β1 correlates with LV remodeling [24]. In patients with aortic stenosis, TGF-β1 concentration decreases 1 year after aortic valve replacement [25]. Evidence suggests a close association between the renin-angiotensin-aldosterone system and TGF-β1.…”

TGFB1 disrupts the angiogenic potential of microvascular endothelial cells of the corpus luteum

“…2A). The physiological concentration of 1 ng/ml TGFB1 (Fukuchi et al, 2004;Kiliç et al, 2009;Ouellete et al, 2005;Villar et al, 2009) seemed to be maximally effective for phosphorylation of SMAD2 and SMAD3. Time-course experiments revealed that both SMAD2 and SMAD3 were phosphorylated within 5 minutes following treatment with TGFB1 (1 ng/ml) (Fig.…”

Shear-Sensitive Genes in Aortic Valve Endothelium

“…Endothelial nitric oxide synthase (eNOS) is upregulated in laminar flow, which induces nitric oxide generation and release outside of the cell. To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars Villar et al (125) found that circulating plasma levels of TGF-b1, the most abundant isoform of the TGF-b family, in patients with aortic stenosis were nearly threefold higher than in healthy controls. Yetkin et al (141) studied patients with tricuspid calcified and stenotic aortic valves and found that the calcified valves presented similarly increased expression of TGF-b1.…”